Paternal advanced age and sperm quality are indicators for Preimplantation Genetic Testing in egg donation cycles

Background: A wide variety of studies demonstrate the influence of the oocyte source's age on the success of assisted reproduction treatments; however, the effect of paternal age has been studied to a lesser extent. Therefore, our goal was to assess the impact of male age and sperm quality on i...

Full description

Saved in:
Bibliographic Details
Main Authors: Jeimy Pedraza (Author), Hugo Sierra (Author), Jacqueline Cordero (Author), Esther López-Bayghen (Author)
Format: Book
Published: IMR Press, 2021-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d13f9e60e9b94f9bbc8a305b68bf9a03
042 |a dc 
100 1 0 |a Jeimy Pedraza  |e author 
700 1 0 |a Hugo Sierra  |e author 
700 1 0 |a Jacqueline Cordero  |e author 
700 1 0 |a Esther López-Bayghen  |e author 
245 0 0 |a Paternal advanced age and sperm quality are indicators for Preimplantation Genetic Testing in egg donation cycles 
260 |b IMR Press,   |c 2021-12-01T00:00:00Z. 
500 |a 0390-6663 
500 |a 10.31083/j.ceog4806222 
520 |a Background: A wide variety of studies demonstrate the influence of the oocyte source's age on the success of assisted reproduction treatments; however, the effect of paternal age has been studied to a lesser extent. Therefore, our goal was to assess the impact of male age and sperm quality on in vitro fertilization (IVF) outcomes. Methods: Three hundred ninety-four ova donation IVF cycles from Ingenes México were retrospectively analyzed. All ova donors (age range: 18-35 years) underwent a similar IVF stimulation protocol. The oocytes were aspirated and inseminated by intracytoplasmic sperm injection (ICSI) using either partner sperm (n = 332, age: 42.4 ± 7.4 years) or donor sperm (n = 62, age: 25.0 ± 3.3 years). Semen characteristics were evaluated by a seminogram. Biopsies were performed on Day 5 or Day 6, and Preimplantation Genetic Testing for Aneuploidies (PGT-A) was used to determine chromosome integrity with Next-Generation Sequencing. Results: A total of 1449 embryos were biopsied, 995 Day 5 and 454 Day 6. The aneuploidy rates for Day 5 and Day 6 embryos were not significantly different (22.2% and 22.7%, respectively). Independent of the sperm source, there was no observable trend between embryo aneuploidy rates and the sperm source's age; however, when considering paternal sperm with teratozoospermia, a significant association was observed (rho = 0.165, p = 0.041). Sperm quality showed no effect on fertilization rates, blastocyst formation, or implantation rates. Discussion: Here, the sperm source's age did not affect the aneuploidy rate nor embryo implantation; however, with teratozoospermia, there was a weak association between the aneuploidy rate and age. Therefore, it would be prudent to perform PGT-A when advanced age and teratozoospermia are detected. 
546 |a EN 
690 |a aneuploidy 
690 |a egg donor 
690 |a in vitro fertilization 
690 |a paternal age 
690 |a preimplantation genetic screening 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n Clinical and Experimental Obstetrics & Gynecology, Vol 48, Iss 6, Pp 1404-1411 (2021) 
787 0 |n https://www.imrpress.com/journal/CEOG/48/6/10.31083/j.ceog4806222 
787 0 |n https://doaj.org/toc/0390-6663 
856 4 1 |u https://doaj.org/article/d13f9e60e9b94f9bbc8a305b68bf9a03  |z Connect to this object online.